Your browser doesn't support javascript.
loading
Inflammation, Attention, and Processing Speed in Patients With Breast Cancer Before and After Chemotherapy.
Belcher, Elizabeth K; Culakova, Eva; Gilmore, Nikesha J; Hardy, Sara J; Kleckner, Amber S; Kleckner, Ian R; Lei, Lianlian; Heckler, Charles; Sohn, Michael B; Thompson, Bryan D; Lotta, Louis T; Werner, Zachary A; Geer, Jodi; Hopkins, Judith O; Corso, Steven W; Rich, David Q; van Wijngaarden, Edwin; Janelsins, Michelle C.
Afiliação
  • Belcher EK; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Culakova E; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Gilmore NJ; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Hardy SJ; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Kleckner AS; Department of Radiation Oncology and Neurology, University of Rochester Medical Center, Rochester, NY, USA.
  • Kleckner IR; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Lei L; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Heckler C; Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
  • Sohn MB; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Thompson BD; Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA.
  • Lotta LT; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Werner ZA; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Geer J; Department of Surgery, Supportive Care in Cancer Division, University of Rochester Medical Center, Rochester, NY, USA.
  • Hopkins JO; Metro Minnesota Community Oncology Research Consortium, Louis Park, MN, USA.
  • Corso SW; Novant Health Cancer Institute, Kernersville, NC, USA.
  • Rich DQ; Upstate Carolina National Cancer Institute Community Oncology Research Program, Spartanburg Regional Medical Center, Spartanburg, SC, USA.
  • van Wijngaarden E; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.
  • Janelsins MC; Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA.
J Natl Cancer Inst ; 114(5): 712-721, 2022 05 09.
Article em En | MEDLINE | ID: mdl-35134984
ABSTRACT

BACKGROUND:

Inflammation may contribute to cognitive difficulties in patients with breast cancer. We tested 2 hypotheses inflammation is elevated in patients with breast cancer vs noncancer control participants and inflammation in patients is associated with worse attention and processing speed over the course of chemotherapy.

METHODS:

Serum cytokines (interleukin [IL]-4, 6, 8, 10; tumor necrosis factor [TNF]-α) and soluble receptors [sTNFRI, II]) were measured in 519 females with breast cancer before and after chemotherapy and 338 females without cancer serving as control participants. Attention and processing speed were measured by Rapid Visual Processing (RVP), Backward Counting (BCT), and Trail Making-A (TMT-A) tests. Linear regression models examined patient vs control cytokines and receptor levels, adjusting for covariates. Linear regression models also examined relationships between patient cytokines and receptor levels and test performance, adjusting for age, body mass index, anxiety, depression, cognitive reserve, and chemotherapy duration. Statistical tests were 2-sided (α = .05).

RESULTS:

sTNFRI and sTNFRII increased over time in patients relative to controls, whereas IL-4, IL-6, and IL-10 decreased. Prechemotherapy, higher IL-8 associated with worse BCT (ß = 0.610, SE = 0.241, P = .01); higher IL-4 (ß = -1.098, SE = 0.516, P = .03) and IL-10 (ß = -0.835, SE = 0.414, P = .04) associated with better TMT-A. Postchemotherapy, higher IL-8 (ß = 0.841, SE = 0.260, P = .001), sTNFRI (ß = 6.638, SE = 2.208, P = .003), and sTNFRII (ß = 0.913, SE = 0.455, P = .045) associated with worse BCT; higher sTNFRII also associated with worse RVP (ß = -1.316, SE = 0.587, P = .03). At prechemotherapy, higher IL-4 predicted RVP improvement over time (ß = 0.820, SE = 0.336, P = .02); higher sTNFRI predicted worse BCT over time (ß = 5.566, SE = 2.367, P = .02). Longitudinally, increases in IL-4 associated with BCT improvement (ß = -0.564, SE = 0.253, P = .03).

CONCLUSIONS:

Generally, worse attention and processing speed were associated with higher inflammatory cytokines and receptors and lower anti-inflammatory cytokines in patients; future confirmatory studies are needed.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article